France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country. ...
Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said he it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of in ...
Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said he it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of in ...
The first batch of Sputnik vaccine is expected to be produced at Serum Institute of India (SII)'s facilities in September, said Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund on Tuesday. ...
Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday. ...
Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines. ...
The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe. ...
An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sourc ...
EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. ...
